These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32175161)

  • 1. Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma.
    Ömeroğlu Şimşek G; Ağababaoğlu İ; Dursun D; Özekinci S; Erçetin P; Ellidokuz H; Aktaş S; Gürel D; Öztop İ; Akkoçlu A
    Turk Gogus Kalp Damar Cerrahisi Derg; 2020 Jan; 28(1):188-196. PubMed ID: 32175161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
    Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
    Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
    Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A
    Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.
    Masiuk M; Waloszczyk P; Lewandowska M; Dobak E; Urasinska E
    Thorac Cancer; 2020 Sep; 11(9):2529-2535. PubMed ID: 32671956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
    Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
    Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
    Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
    Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.
    Halimi M; BeheshtiRouy S; Salehi D; Rasihashemi SZ
    Iran J Pathol; 2019; 14(2):122-126. PubMed ID: 31528168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
    Kawai T; Greenberg SD; Truong LD; Mattioli CA; Klima M; Titus JL
    Am J Pathol; 1988 Feb; 130(2):401-10. PubMed ID: 2449084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma.
    Bakir K; Koçer NE; Deniz H; Güldür ME
    Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?
    Bozdag Z; Tutar E; Dizibuyuk OF; Bakir K
    Pathol Oncol Res; 2020 Jul; 26(3):1651-1656. PubMed ID: 31512057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.
    Chaouche-Mazouni S; Scherpereel A; Zaamoum R; Mihalache A; Amir ZC; Lebaïli N; Delaire B; Gosset P
    Ann Diagn Pathol; 2015 Aug; 19(4):193-7. PubMed ID: 25935651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
    Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
    Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
    Sakuma N; Kamei T; Ishihara T
    Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel markers for the diagnosis of malignant pleural mesothelioma.
    Gueugnon F; Leclercq S; Blanquart C; Sagan C; Cellerin L; Padieu M; Perigaud C; Scherpereel A; Gregoire M
    Am J Pathol; 2011 Mar; 178(3):1033-42. PubMed ID: 21356356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of COL1A1 and COL1A2 genes in malignant pleural mesothelioma tissues].
    Li B; Pu YQ; Li ZL; Zhao Y; Zi JJ; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Jul; 40(7):487-494. PubMed ID: 35915937
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.